Inovio Pharmaceuticals Stock Price on March 7, 2024

INO Stock  USD 4.19  0.18  4.49%   
Below is the normalized historical share price chart for Inovio Pharmaceuticals extending back to December 08, 1998. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Inovio Pharmaceuticals stands at 4.19, as last reported on the 28th of November, with the highest price reaching 4.25 and the lowest price hitting 4.01 during the day.
IPO Date
12th of February 1998
200 Day MA
8.6264
50 Day MA
5.4452
Beta
0.833
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Inovio Stock, it is important to understand the factors that can impact its price. Inovio Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.23, which attests that the entity had a -0.23% return per unit of risk over the last 3 months. Inovio Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Inovio Pharmaceuticals' Risk Adjusted Performance of (0.19), market risk adjusted performance of (0.44), and Standard Deviation of 3.35 to validate the risk estimate we provide.
  
At this time, Inovio Pharmaceuticals' Common Stock Shares Outstanding is very stable compared to the past year. As of the 28th of November 2024, Other Stockholder Equity is likely to grow to about 1.8 B, while Total Stockholder Equity is likely to drop about 95.2 M. . As of the 28th of November 2024, Price To Sales Ratio is likely to drop to 154.95. In addition to that, Price Earnings Ratio is likely to drop to -1.05. Inovio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2324

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsINO

Estimated Market Risk

 3.44
  actual daily
30
70% of assets are more volatile

Expected Return

 -0.8
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.23
  actual daily
0
Most of other assets perform better
Based on monthly moving average Inovio Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inovio Pharmaceuticals by adding Inovio Pharmaceuticals to a well-diversified portfolio.
Price Book
1.4658
Enterprise Value Ebitda
(1.09)
Price Sales
176.8347
Shares Float
23.5 M
Wall Street Target Price
10.6667

Inovio Pharmaceuticals Valuation on March 7, 2024

It is possible to determine the worth of Inovio Pharmaceuticals on a given historical date. On March 7, 2024 Inovio was worth 9.65 at the beginning of the trading date compared to the closed value of 9.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Inovio Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Inovio Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inovio Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Inovio Pharmaceuticals' related companies.
 Open High Low Close Volume
  9.84    10.31    9.67    9.87    757,692  
03/07/2024
  9.65    9.71    8.35    9.03    836,194  
  9.00    10.74    8.97    10.18    1,051,860  
Backtest Inovio Pharmaceuticals  |  Inovio Pharmaceuticals History  |  Inovio Pharmaceuticals Valuation   PreviousNext  
Open Value
9.65
9.03
Closing Value
19.98
Upside

Inovio Pharmaceuticals Trading Date Momentum on March 7, 2024

On March 08 2024 Inovio Pharmaceuticals was traded for  10.18  at the closing time. Highest Inovio Pharmaceuticals's price during the trading hours was 10.74  and the lowest price during the day was  8.97 . The net volume was 1.1 M. The overall trading history on the 8th of March contributed to the next trading period price boost. The trading delta at closing time to the next next day price was 12.74% . The trading delta at closing time to current price is 16.39% .

Inovio Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Inovio Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Inovio Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Inovio financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Inovio Pharmaceuticals Stock history

Inovio Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Inovio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Inovio Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Inovio Pharmaceuticals stock prices may prove useful in developing a viable investing in Inovio Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding22.2 M28 M
Net Loss-251.8 M-239.2 M

Inovio Pharmaceuticals Quarterly Net Working Capital

67.79 Million

Inovio Pharmaceuticals Stock Technical Analysis

Inovio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Inovio Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Inovio Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Inovio Pharmaceuticals Period Price Range

Low
November 28, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Inovio Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Inovio Pharmaceuticals November 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Inovio Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inovio Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Inovio Pharmaceuticals stock market strength indicators, traders can identify Inovio Pharmaceuticals entry and exit signals to maximize returns

Inovio Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Inovio Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Inovio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Inovio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Inovio Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inovio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inovio Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inovio Pharmaceuticals Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.43)
Revenue Per Share
0.025
Quarterly Revenue Growth
(0.55)
Return On Assets
(0.40)
Return On Equity
(0.91)
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.